Search Results - "Caro Vega, Y."

Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas by Crabtree Ramírez, B., Caro Vega, Y., Shepherd, B.E., Le, C., Turner, M., Frola, C., Grinsztejn, B., Cortes, C., Padgett, D., Sterling, T.R., McGowan, C.C., Person, A.

“…•This is a description of clinical outcomes of cryptococcal meningitis (CM) in persons with HIV-infection in a large Latin-American cohort.•Mortality in…”
Get full text

Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capital by Núñez, I., Caro-Vega, Y., Belaunzarán-Zamudio, P.F.

“…Case definitions are vital in a pandemic to effectively identify, isolate, and contact trace, particularly where testing is slow, scant, or not available…”
Get full text

Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge by Caro-Vega, Y, Belaunzarán-Zamudio, P F, Crabtree-Ramírez, B, Shepherd, B E, Mejia, F, Giganti, M J, Patterson, P, Grinsztejn, B, Wolff, M, Pape, J W, Padgett, D, Castilho, J L, McGowan, C, Sierra-Madero, J G

“…We aimed to quantify the proportion of people receiving care for HIV-infection that are 50 years or older (older HIV patients) in Latin America and the…”
Get full text

The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis by Ortiz-Brizuela, E., Caro-Vega, Y., Bobadilla-del-Valle, M., Leal-Vega, F., Criollo-Mora, E., López Luis, B.A., Esteban-Kenel, V., Torres-Veintimilla, E., Galindo-Fraga, A., Olivas-Martínez, A., Tovar-Calderón, E., Torres-González, P., Sifuentes-Osornio, J., Ponce-de-León, A.

“…Carbapenem non-susceptible Enterobacterales (CNSE) can be broadly divided into those that produce carbapenemases (carbapenemase-producing Enterobacterales…”
Get full text

Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed by Núñez, Isaac, Caro-Vega, Yanink, MacDonald, Conor, Mosqueda-Gómez, Juan Luis, Piñeirúa-Menéndez, Alicia, Matthews, Anthony A

“…Abstract Background We aimed to determine the effectiveness of switching to bictegravir in maintaining an undetectable viral load (<50 copies/mL) among people…”
Get full text

The clinical effects of durably low CD4 counts while virologically suppressed among ART-initiating persons with HIV in Latin America by Caro-Vega, Y, Rebeiro, P.F, Shepherd, B.E, Belaunzaran-Zamudio, P.F, Crabtree-Ramirez, B, Cesar, C, Luz, P Mendes, Cortes, C, Padget, D, Gotuzzo, E, Gowan, C.C. Mc, Sierra-Madero, J

Get full text

Virological and immunological response to highly active antiretroviral therapy in patients over 50 years of age in a cohort of patients in Mexico by Beltran Santiago, D, Caro Vega, Y, Crabtree-Ramirez, B, Sierra-Madero, J

Get full text

Diagnosis of HIV infection over 50 years. Clinical and epidemiological implications by Beltran Santiago, D, Caro Vega, Y, Sierra-Madero, J, Crabtree-Ramirez, B

Get full text

A literature review of reporting standards of HIV progression models by COLCHERO, M. Arantxa, CARO-VEGA, Yanink N, SANCHEZ-CONZALEZ, Gilberto, BAUTISTA-ARREDONDO, Sergio

“…We conducted a systematic review of HIV progression models to identify the mathematical structures used, the main research questions and key model aspects in…”
Get full text